DOXORUBICIN HYDROCHLORIDE
- Product NDC
- 68001-704
- 11-digit product format
- 680010704
- Labeler code
- 68001
- Product ID
- 68001-704_4dff7ee8-c0a2-c78d-e063-6394a90a79e8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- doxorubicin hydrochloride
- Dosage form
- INJECTABLE, LIPOSOMAL
- Route
- INTRAVENOUS
- Labeler
- BluePoint Laboratories
- Application
- ANDA212299
- Marketing category
- ANDA
- Marketing start
- 2026-04-02
- Substance
- DOXORUBICIN HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- DOXORUBICIN HYDROCHLORIDE
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXORUBICIN HYDROCHLORIDE | 2 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 82F2G7BL4E |
| Rxcui | 1790115, 1790127 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68001-704-26 | DOXORUBICIN HYDROCHLORIDE | 1 in 1 CARTON | INJECTABLE, LIPOSOMAL | 1 | | 1 |
| 68001-704-26 | DOXORUBICIN HYDROCHLORIDE | 25 mL in 1 VIAL, SINGLE-DOSE | INJECTABLE, LIPOSOMAL | 25 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 68001-704-26 | 68001070426 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-704-26) / 25 mL in 1 VIAL, SINGLE-DOSE | 2026-04-02 | No | No | Current |